TP Therapeutics
TP Therapeutics is a clinical-stage biopharmaceutical company that is focusing on overcoming drug resistance in precision medicines for cancer and other diseases.
2
Funding Rounds
$125.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| At**** Co*********** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa***** Ma***** | - | - | - |
| Si**** Ge**** | - | - | - |
| Ba***** Bo*** | - | - | - |
| Ca*** Ga******* | - | - | |
| Ma** Al*** | - | - | |
| Ga*** Ni******* | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| At**** Co*********** | - | - |
Funding
Funding series
Funding Series Analysis
The company TP Therapeutics has raised a total of $125m in funding over 2 rounds.
Key Insights:
- TP Therapeutics , October 2018: $80m
- TP Therapeutics Series C round, May 2017: $45m
TP Therapeutics , October 2018
$80m
TP Therapeutics Series C round, May 2017
$45m
Industries
TP Therapeutics is active in the following industries:
- Healthcare
- Cancer
- Oncology
- Internal medicine
- Medicine